2021
DOI: 10.7759/cureus.19977
|View full text |Cite
|
Sign up to set email alerts
|

Y Chromosome Material in Turner Syndrome

Abstract: BackgroundTurner Syndrome (TS) is a frequently identified chromosomal disease in humans characterized by short stature, sexual infantilism, streak gonads, primary amenorrhea, and a number of somatic anomalies. Approximately 55% of TS individuals have a nonmosaic 45,X karyotype. In addition, a cell line with a Y chromosome is present in 5% of patients, which is undetectable by the standard cytogenetic analysis. The identification of Y chromatin in some TS individuals has been associated with the development of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 20 publications
0
1
0
Order By: Relevance
“…Karyotyping identifies a normal or structurally aberrant Y chromosome in 5%–12% of TS patients. Despite the apparent Y chromosome detection in TS patients, molecular studies such as polymerase chain reaction (PCR) and fluorescence in situ hybridization (FISH) (Akcan & Boduroglu, 2021 ; Bispo et al, 2014 ; Chen et al, 2021 ; Cortes‐Gutierrez et al, 2012 ; Silva‐Grecco et al, 2016 ) have heightened the identification of concealed Y chromosome material in TS patients, consequently elevating the Y‐chromosome sequence detection rate to approximately 60% (de Marqui et al, 2016 ). Furthermore, the risk of GB development among patients with cryptic Y chromosome material mirrors that of individuals possessing overt Y chromosome anomalies (Kwon et al, 2017 ).…”
Section: Discussionmentioning
confidence: 99%
“…Karyotyping identifies a normal or structurally aberrant Y chromosome in 5%–12% of TS patients. Despite the apparent Y chromosome detection in TS patients, molecular studies such as polymerase chain reaction (PCR) and fluorescence in situ hybridization (FISH) (Akcan & Boduroglu, 2021 ; Bispo et al, 2014 ; Chen et al, 2021 ; Cortes‐Gutierrez et al, 2012 ; Silva‐Grecco et al, 2016 ) have heightened the identification of concealed Y chromosome material in TS patients, consequently elevating the Y‐chromosome sequence detection rate to approximately 60% (de Marqui et al, 2016 ). Furthermore, the risk of GB development among patients with cryptic Y chromosome material mirrors that of individuals possessing overt Y chromosome anomalies (Kwon et al, 2017 ).…”
Section: Discussionmentioning
confidence: 99%